Skip to main content
https://pbs.twimg.com/media/Fhjn8G3X0AIjfcw.jpg
BD-2 novel, PsA-specific predictive biomarker of clinical arthritis response to SEC. Pts w/ high levels of BD-2 at baseline reach and sustain higher rates of clinical response after tx w/ SEC. Abs 2148 #ACR22 @RheumNow https://t.co/9ZJz2C0Pep https://t.co/5gf2O7B0c5
Dr. Rachel Tate
14-11-2022
×